For how a diffuse type of hair loss differs in principle from patterned forms, we explain it in detail in our foundational article
Tirzepatide is generally not appropriate for people who are pregnant, planning pregnancy, or breastfeeding, or for anyone with a personal or family history of medullary thyroid carcinoma or MEN 2
Contact your compounding pharmacy and healthcare provider immediately
A 2025 meta-analysis published in Endocrinology, Diabetes & Metabolism, pooling data from four studies with nearly 29,000 patients, confirmed a consistent advantage for tirzepatide, with an average additional weight reduction of 4.84 kg compared to semaglutide
These visits allow for blood pressure monitoring, medication adjustments, and assessment of weight loss progress
Side Effects Both medications are associated with gastrointestinal (GI) issues